ENANTA PHARMACEUTICALS INC — Director's Dealing 2021

Jan 27, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENANTA PHARMACEUTICALS INC (ENTA)
CIK: 0001177648
Period of Report: 2021-01-25

Reporting Person: Luu Brendan (Sr. VP, Business Dev.)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-25	Stock Option (right to buy)	$48.03	A	75000	Acquired	2031-01-25	Common Stock (75000)	Direct

Footnotes

F1: Twenty-five percent (25%) of such option will become exercisable on January 25, 2022 (the "Anniversary Date"), with the remainder to become exercisable quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over three years from the Anniversary Date (in each case subject to the optionholder's continued employment).